ZyVersa Therapeutics, Inc. (ZVSA)
Total Valuation
ZVSA has a market cap or net worth of $6.00 million. The enterprise value is $2.87 million.
Market Cap | 6.00M |
Enterprise Value | 2.87M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
Earnings Date | May 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 7.59 million shares outstanding. The number of shares has increased by 212.03% in one year.
Shares Outstanding | 7.59M |
Shares Change (YoY) | +212.03% |
Shares Change (QoQ) | +10.16% |
Owned by Insiders (%) | 0.83% |
Owned by Institutions (%) | 3.00% |
Float | 4.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.54 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.33, with a Debt / Equity ratio of 0.00.
Current Ratio | 0.33 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 235,786.07 |
Financial Efficiency
Return on equity (ROE) is -287.30% and return on invested capital (ROIC) is -972.23%.
Return on Equity (ROE) | -287.30% |
Return on Assets (ROA) | -210.50% |
Return on Capital (ROIC) | -972.23% |
Revenue Per Employee | n/a |
Profits Per Employee | -$15.18M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -9.46M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.93% in the last 52 weeks. The beta is 0.64, so ZVSA's price volatility has been lower than the market average.
Beta (1Y) | 0.64 |
52-Week Price Change | -98.93% |
50-Day Moving Average | 0.74 |
200-Day Moving Average | 3.64 |
Relative Strength Index (RSI) | 44.78 |
Average Volume (30 Days) | 2,785,406 |
Short Selling Information
The latest short interest is 645,991, so 8.51% of the outstanding shares have been sold short.
Short Interest | 645,991 |
Short Previous Month | 1.19M |
Short % of Shares Out | 8.51% |
Short % of Float | 16.15% |
Short Ratio (days to cover) | 0.10 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -107.75M |
Pretax Income | -107.75M |
Net Income | -106.25M |
EBITDA | -107.74M |
EBIT | -107.75M |
Earnings Per Share (EPS) | -$108.97 |
Balance Sheet
The company has $3.14 million in cash and $8,656 in debt, giving a net cash position of $3.13 million or $0.41 per share.
Cash & Cash Equivalents | 3.14M |
Total Debt | 8,656 |
Net Cash | 3.13M |
Net Cash Per Share | $0.41 |
Equity / Book Value | 11.07M |
Book Value Per Share | 1.46 |
Working Capital | -6.84M |
Cash Flow
Operating Cash Flow | -8.72M |
Capital Expenditures | n/a |
Free Cash Flow | -8.72M |
FCF Per Share | -$8.94 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ZVSA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -212.03% |
Shareholder Yield | -212.03% |
Earnings Yield | -1,771.24% |
FCF Yield | -145.39% |
Analyst Forecast
The average price target for ZVSA is $12.00, which is 1,500.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.00 |
Price Target Difference | 1,500.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -2.78% |
Stock Splits
The last stock split was on December 5, 2023. It was a reverse split with a ratio of 1:35.
Last Split Date | Dec 5, 2023 |
Split Type | Reverse |
Split Ratio | 1:35 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |